Criteria | Number of patients | |
---|---|---|
1 | Number of beneficiaries under 65 at eligibility start | 4,729,443 |
2 | >1 breast, ovarian, head and neck, or nonsmall cell lung cancer claim from 1999–2005 | 56,261 |
3 | >1 chemotherapy treatment within 3 months following a breast, ovarian, head and neck, or nonsmall cell lung cancer diagnosis | 14,142 |
4 | >3 months of continuous eligibility prior to the first chemotherapy treatment for the qualifying tumor during which no other chemotherapy treatment was received | 11,009 |
5 | >1 diagnosis for peripheral neuropathy following first chemotherapy treatment | 1,245 |
6 | Peripheral neuropathy within 9 months of first chemotherapy treatment | 525 |
Main CAPN sample: no diabetes history | 454 | |
Diabetic CAPN sample | 71 | |
Employee CAPN subsample | 78 |